Biomaterial‐Mediated Metabolic Regulation of Ferroptosis for Cancer Immunotherapy

ABSTRACT Ferroptosis is a lipid peroxidation‐driven cell death route and has attracted enormous interest for cancer therapy. Distinct from other forms of regulated cell death, its process is involved with multiple metabolic pathways including lipids, bioenergetics, iron, and so on, which influence cancer cell ferroptosis sensitivity and communication with the immune cells in the tumor microenvironment. Development of novel technologies for harnessing the ferroptosis‐associated metabolic regulatory network would profoundly improve our understanding of the immune responses and enhance the efficacy of ferroptosis‐dependent immunotherapy. Interestingly, the recent advances in bio‐derived material‐based therapeutic platforms offer novel opportunities to therapeutically modulate tumor metabolism through the in situ delivery of molecular or material cues, which not only allows the tumor‐specific elicitation of ferroptosis but also holds promise to maximize their immunostimulatory impact. In this review, we will first dissect the crosstalk between tumor metabolism and ferroptosis and its impact on the immune regulation in the tumor microenvironment, followed by the comprehensive analysis on the recent progress in biomaterial‐based metabolic regulatory strategies for evoking ferroptosis‐mediated antitumor immunity. A perspective section is also provided to discuss the challenges in metabolism‐regulating biomaterials for ferroptosis‐immunotherapy. We envision that this review may provide new insights for improving tumor immunotherapeutic efficacy in the clinic.